1 Day
Source:
بوابة الشروق
Pharmaceuticals Firm Targets 2026-27 Profits
The holding company for pharmaceuticals in Egypt aims to achieve revenues of up to 18.9 billion Egyptian pounds and a net profit of approximately 3.6 billion Egyptian pounds during the fiscal year 2026-2027. This is part of a plan to serve drug security and enhance productivity. The Deputy Prime Minister clarified that the sector receives significant government attention, focusing on technology localization, increasing manufacturing capacities, and expanding export markets, with a 2514% growth in the market value of subsidiaries over the past four years. The company also plans to expand its research and development efforts and upgrade infrastructure, with 44 new formulations registered and a substantial increase in exports, all of which support drug security and the sustainability of the national economy.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)